KR

Kutumba Rao Puppala

Active Director Director DIN 02316452
DIN 02316452 First appointment Aug 1994 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 1994
Shareholding value •••• Premium profile

About Kutumba Rao Puppala

Data last updated:

Kutumba Rao Puppala is a Director at Viskaan Pharma Pvt Ltd (since 1994). The company operates in Pharma. Viskaan Pharma Pvt Ltd reported revenue of ₹6.48 Cr (FY 2024).

DIN 02316452
Primary Designation Director
Industry Pharma
First Appointment 31 Aug 1994
Oldest Company Age 39 yrs
Largest company Viskaan Pharma Pvt Ltd · ₹6.48 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Viskaan Pharma Pvt Ltd U01222TG1987PTC007510
Director31 Aug 19941987₹6.48 Cr (FY 2024)Active

Board colleagues of Kutumba Rao Puppala

NameDINCompanyDesignation
Kadempally Vijaya Kumar02303899Viskaan Pharma Pvt LtdManaging Director

Directorship timeline

Open interactive timeline →
Viskaan Pharma Pvt Ltd
Premium access

Shareholding and investment profile for Kutumba Rao Puppala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kutumba Rao Puppala

Kutumba Rao Puppala currently holds 1 directorship: Viskaan Pharma Pvt Ltd (Director, since 31 Aug 1994, revenue ₹6.48 Cr (FY 2024)).

Kutumba Rao Puppala was first appointed on 31 Aug 1994 as Director at Viskaan Pharma Pvt Ltd.

The current boards of Kutumba Rao Puppala's companies include Kadempally Vijaya Kumar (Viskaan Pharma Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available